fig3
![Biomarkers in anderson-Fabry disease: what should we use in the clinical practice?](https://image.oaes.cc/e49d83c8-5d57-4f19-b6eb-2b86a21dc08e/rdodj3056.fig.3.jpg)
Figure 3. Proposed study design to evaluate biomarkers. (A) biomarkers to assess patient prognosis; (B) biomarkers to assess response to treatment.
Figure 3. Proposed study design to evaluate biomarkers. (A) biomarkers to assess patient prognosis; (B) biomarkers to assess response to treatment.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/